Legislators
Bills
Statements
Lobbying
Travel
Searching...- Lobbying
- Lobbying by Government Counsel, LLC (obo) Lupin Pharmaceuticals, Inc.
Lobbying Relationship
Bills mentioned
S.1895: Lower Health Care Costs Act
Sponsor: Lamar Alexander (R-Tenn.)
H.R.938: BLOCKING Act of 2019
Sponsor: Kurt Schrader (D-Ore.)
H.R.987: Strengthening Health Care and Lowering Prescription Drug Costs Act
Sponsor: Lisa Blunt Rochester (D-Del.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
| Lobbyist | Covered positions? |
|---|---|
| Lisa Layman | CBO, PA(92-96); LA, Sen Chafee(97-99); LA, Sen Bryan(00); SPA, Sen Graham(01-04); SPA, Sen Stabenow(05-07) SPA, Sen. Stabenow (2005-2007); SPA, Sen. Graham (2001-2004); LA, Sen. Bryan (2000); LA, Sen. Chafee (1997-1999); CBO, PA (1992-1996) |
| Martin Corry | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate